APA (7th ed.) Citation

ME, C., MJ, V. W., JA, S., TJ, C., CE, S., IM, S., . . . K, S. (2025). Advancing age and sex modulate antidyskinetic efficacy of striatal CaV1.3 gene therapy in a rat model of Parkinson's disease. Neurobiology of aging, 149, 54. https://doi.org/10.1016/j.neurobiolaging.2025.02.003

Chicago Style (17th ed.) Citation

ME, Caulfield, Vander Werp MJ, Stancati JA, Collier TJ, Sortwell CE, Sandoval IM, Kordower JH, Manfredsson FP, and Steece-Collier K. "Advancing Age and Sex Modulate Antidyskinetic Efficacy of Striatal CaV1.3 Gene Therapy in a Rat Model of Parkinson's Disease." Neurobiology of Aging 149 (2025): 54. https://doi.org/10.1016/j.neurobiolaging.2025.02.003.

MLA (9th ed.) Citation

ME, Caulfield, et al. "Advancing Age and Sex Modulate Antidyskinetic Efficacy of Striatal CaV1.3 Gene Therapy in a Rat Model of Parkinson's Disease." Neurobiology of Aging, vol. 149, 2025, p. 54, https://doi.org/10.1016/j.neurobiolaging.2025.02.003.